|
|
Volumn 13, Issue 4, 2008, Pages 279-282
|
|
Do dopamine partial agonists have partial efficacy as antipsychotics?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 [4 [5 (4 FLUOROPHENYL) 3 PYRIDINYLMETHYL] 1 PIPERAZINYL] 1,4 BENZODIOXAN;
8 [4 [3 (5 FLUORO 1H INDOL 3 YL)PROPYL] 1 PIPERAZINYL] 2 METHYL 1,4 BENZOXAZIN 3(4H) ONE;
APLINDORE;
ARIPIPRAZOLE;
BIFEPRUNOX;
CLOZAPINE;
DAB 452;
DM 1451;
DOPAMINE 2 RECEPTOR STIMULATING AGENT;
DOPAMINE RECEPTOR BLOCKING AGENT;
DRUG METABOLITE;
LISURIDE;
MOOD STABILIZER;
NEUROLEPTIC AGENT;
OLANZAPINE;
OPC 4293;
PARTIAL AGONIST;
RGH 188;
RISPERIDONE;
SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;
SEROTONIN UPTAKE INHIBITOR;
TERGURIDE;
WAY 13592;
BIPOLAR DEPRESSION;
DOSE RESPONSE;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG POTENCY;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
HYPERPROLACTINEMIA;
LOW DRUG DOSE;
MAJOR DEPRESSION;
MANIA;
NEGATIVE SYNDROME;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
PSYCHOSIS;
REVIEW;
SCHIZOPHRENIA;
WEIGHT GAIN;
|
|
EID: 43249084428
PISSN: 10928529
EISSN: None
Source Type: Journal
DOI: 10.1017/S1092852900016382 Document Type: Review |
|
Times cited : (24)
|
|
References (18)
|
